Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
about
Elk3 deficiency causes transient impairment in post-natal retinal vascular development and formation of tortuous arteries in adult murine retinaeAngiopoietin-Tie signalling in the cardiovascular and lymphatic systemsTie1 controls angiopoietin function in vascular remodeling and inflammation.Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization.The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammationHematopoietic stem and progenitor cells regulate the regeneration of their niche by secreting Angiopoietin-1Phosphorylation of Threonine 794 on Tie1 by Rac1/PAK1 Reveals a Novel Angiogenesis Regulatory Pathway.HSPA12B: a novel facilitator of lung tumor growthLymphangiogenic factors, mechanisms, and applications.Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.Tie-1: A potential target for anti-angiogenesis therapy.Multilineage communication regulates human liver bud development from pluripotency.Therapeutic targeting of the angiopoietin-TIE pathway.Angiopoietins and Tie2 in vascular inflammation.Engineering a vascularised 3D in vitro model of cancer progression.Elevated expression of Tie1 is accompanied by acquisition of cancer stemness properties in colorectal cancer.Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts.Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP.Endothelial Tie1-mediated angiogenesis and vascular abnormalization promote tumor progression and metastasis.Angiopoietin-4-dependent venous maturation and fluid drainage in the peripheral retina
P2860
Q27348777-5EF03F03-1ECE-424A-8FA4-7BBFBFC3CD72Q28070234-3A836B68-5606-4D0B-84D6-D7F9CF3101DDQ30805233-81C3E29D-8BD5-4508-9D5F-F4389D5DC53FQ33620110-C241A33C-D932-4A7F-9322-EB88D03E5104Q35212821-D2AA8BD0-A7EE-4282-9594-4455A5298453Q35543933-62941760-504A-4BDD-98E7-203ED8222165Q35799103-5ADEB3FB-E8B2-4FDA-B03C-9D7374AE51F0Q35833194-16122589-CF7D-4DF9-B9AE-9329FCA4AB21Q38192927-1D904B45-DF8E-40B9-A2EF-802707A5018EQ38259982-23917CBF-4BE7-4707-AE40-4F3B08982E67Q38613313-B7AE34BC-D166-491E-A9FB-1DE1013457FCQ38725847-28E6A8FE-A557-4628-87AF-9FFC1AA1D701Q39321127-B7C065F3-9874-47FF-8980-2A092FC2B1F6Q39352145-256FBA87-A045-41F7-A1C9-D49098211E58Q41920409-E37A102C-350E-49C0-8DD4-069E816EEE64Q42215410-95751D6B-C1BC-403A-96DA-BDC8E13AF03FQ42374080-1D15DD3C-79F2-46FC-92D4-484EAC39BDB8Q47846359-D16D4126-30AC-4DBD-9B9E-02FBB14C96F8Q49884417-4BC3C050-8D91-436E-BC57-014A235D08F2Q59126431-2BDDD499-8F11-4325-81D7-3060468ECD2B
P2860
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
@en
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.
@nl
type
label
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
@en
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.
@nl
prefLabel
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
@en
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.
@nl
P2093
P2860
P50
P356
P1476
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
@en
P2093
Andrey Anisimov
Emilia A Korhonen
Gabriela D'Amico
Georgia Zarkada
Gou Young Koh
Harri Elamaa
Lauri Eklund
Raija Sormunen
René Hägerling
Rolf A Brekken
P2860
P304
P356
10.1172/JCI68897
P407
P577
2014-01-16T00:00:00Z